For Physicians & Dentists · passive income investments for doctors
By Yuri Rutman, Writer/Director & Producer, The Violinist (Filmdemand). Educational content only — not investment advice.
Beyond Real Estate: What High-Income Doctors Are Missing in Their Alternative Sleeve
Ask most physician-focused advisors about passive income investments for doctors and you will hear one word: real estate. It is a fine answer. It is also an incomplete one, and the gap is where some of the most interesting risk-adjusted opportunities sit.
Why real estate became the default answer
There are good reasons real estate dominates physician alternative-investing content. It produces tangible cash flow. It offers genuine tax features through depreciation. It is easy to understand — everyone grasps an apartment building. And an entire industry of syndicators has grown up specifically to raise capital from doctors, which means the content, the conferences, and the referrals all point the same direction.
None of that makes real estate wrong. It makes it crowded, and it makes it the answer you will hear whether or not it is the best fit for your specific situation. The physician who only ever hears "real estate" is not getting diversification advice; they are getting the output of a sales channel. A genuinely diversified alternative sleeve holds more than one category, precisely so that a downturn in any single one — including real estate, which is highly rate-sensitive — does not take the whole sleeve with it.
The categories doctors under-use
Private credit. As direct lending has grown into a multi-trillion-dollar market, senior secured lending has offered yields well above public fixed income with historically low default rates. For a physician who wants income rather than appreciation, a quality private credit position can do what a bond ladder cannot in the current environment. The diligence is on the manager's underwriting discipline and loss history, not on any single loan.
Direct and single-asset private equity. Rather than a blind-pool fund, some accredited investors take direct positions in a single operating company or a single project through a special purpose vehicle. The appeal is transparency — you can see and diligence exactly one thing — and the absence of fund-level fees. The risk is concentration, which is why these belong sized small.
Uncorrelated niche assets. Farmland, litigation finance, royalties, and entertainment sit here. Their defining feature is that their returns are driven by something that has nothing to do with interest rates or the S&P 500. Litigation finance depends on case outcomes. Farmland depends on crop yields and land values. Film depends on audiences. For a portfolio already heavy in market-correlated assets, a small position in something genuinely uncorrelated does more for whole-portfolio risk than another correlated holding, even a good one.
Film as the clearest example of the gap
Film is worth singling out, not because it is safe — it is not; most independent films do not return investor capital — but because it illustrates the gap so cleanly. It is uncorrelated with markets. It is asymmetric, with a hard floor of total loss and a genuine multiple on the upside. And it carries a distinctive tax profile: Section 168(k) bonus depreciation on placed-in-service timing, plus a pending federal 20% production credit moving through Congress that no physician-finance content is yet discussing.
Precisely because the category has a bad promoter history, the disciplined version is rare and valuable: a single-film structure with a genuine priority return, where investors recoup capital plus a premium before any producer participation, fully financed, with a credible distribution plan. That is a very different instrument from the reputation the category carries, and it is the kind of thing a real-estate-only advisor will never put in front of you — not because it is wrong for you, but because it is not what they sell.
Building a real sleeve
The point is not to replace real estate. It is to stop treating real estate as the entire alternative allocation. A physician sleeve capped at, say, 10 to 15% of investable assets might hold real estate as its largest piece, a private credit position for income, and one or two small higher-upside satellites in genuinely uncorrelated categories.
Diligence every piece the same way: structure before story, operator track record over a full cycle, fully-financed and transparent over opaque, and after-tax modeling at several outcomes. Demand a priority return wherever the structure allows one. And size each satellite so that its total loss is an annoyance, not an event.
The correlation point, made concrete
Diversification is one of those words that gets nodded at and ignored. Made concrete, it means this: in a genuine market downturn, most of what a physician owns tends to fall together. Public equities fall. Rate-sensitive real estate often falls. Even private equity marks down eventually. A portfolio that looks diversified across ten holdings can behave like a single holding when it matters, because all ten respond to the same macro forces.
The value of a genuinely uncorrelated asset is that it is not listening to those forces. A film's return depends on whether audiences show up, which has nothing to do with the Federal Reserve. Farmland responds to harvests and land values. Litigation finance responds to court outcomes. None of these will save a portfolio single-handedly, but a small allocation to something that genuinely marches to a different drummer does more for whole-portfolio stability than yet another holding that marches to the same one.
What 'disciplined' looks like in an uncorrelated bet
Uncorrelated does not mean safe, and the categories that offer the most diversification often carry the most idiosyncratic risk. Discipline in this sleeve is about structure and sizing rather than avoidance. Structure: demand downside protection appropriate to the category — a priority return in a deal structure, senior positioning in credit, genuine asset backing in a real-asset play. Sizing: keep each position small enough that its total loss is an annoyance, not an event.
Applied to film specifically, this means a single well-structured picture with a genuine priority return, sized as a small satellite, evaluated with the tax profile as an enhancement rather than the thesis.
Fitting the sleeve to your specific situation
The right alternative sleeve is not identical for every physician; it should reflect where the rest of your balance sheet already sits. A physician who already owns significant real estate does not need more real estate for its own sake. One with a portfolio dominated by public equities benefits most from the income and lower-correlation categories. And one whose largest asset is a practice or business should lean hard into things uncorrelated with that business's fortunes.
Map what you already own and what drives its value, then deliberately add exposures driven by different forces. The goal is not to own a little of everything, but to own the specific things your existing portfolio is missing.
The honest downside of every category here
Private credit funds can suffer defaults that exceed their reserves when a credit cycle turns. Real estate can be crushed by rising rates, overleverage, or an operator better at raising money than running buildings. Direct private equity positions can go to zero when a single company fails. And the uncorrelated niche assets, film included, carry idiosyncratic risks precisely as real as the diversification they offer.
Diversification across uncorrelated categories reduces the risk that everything fails at once, but it does nothing to prevent any single position from failing on its own terms. That is why sizing is not a detail but the core discipline.
Where this connects to a live example
The Violinist is being financed through a Regulation D 506(c) single-film structure built around these principles: a genuine priority return ahead of any producer participation, a fully-financed budget, a transparent single-asset structure, and a tax profile grounded in current Section 168(k) law with awareness of the pending federal credit. It is offered only to verified accredited investors through definitive offering documents.
Frequently asked questions
Is real estate the best alternative investment for doctors?
It is a strong core alternative but not the only one. A diversified sleeve also considers private credit, direct private equity, and small allocations to genuinely uncorrelated categories, so a downturn in real estate doesn't sink the whole sleeve.
What uncorrelated alternatives should physicians consider?
Categories whose returns don't track markets — farmland, litigation finance, royalties, and entertainment/film — sized small as satellites, chosen precisely because they diversify a market-heavy portfolio.
How much should a physician allocate to alternatives?
Commonly 5-15% of investable assets across all alternatives combined, decided as a cap before evaluating any single deal, so the allocation drives the deals rather than the reverse.
Request the offering documents
Related guides
Educational information only. Not investment, legal, or tax advice, and not an offer to sell or a solicitation to buy any security. Any offering is made only to verified accredited investors through definitive offering documents. Film investing involves substantial risk, including total loss of capital. Statements about Section 168(k) reflect current law; statements about a federal 20% production credit refer to pending legislation that has not been enacted. Consult your own advisors.